TPG Offers $1.9B For Generic Drug Co. Par Pharmaceutical
An affiliate of Fort Worth, Texas-based private equity firm TPG Capital will hand over $1.9 billion in cash for Par Pharmaceutical Cos. Inc., a generics specialist, to cash in on growing...To view the full article, register now.
Already a subscriber? Click here to view full article